Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Pilot study of topical imiquimod combined with pembrolizumab for unresectable cutaneous metastatic melanoma.
Journal: Frontiers in oncology
Published: January 27, 2026
Immune Checkpoint Inhibitors in Unresectable or Metastatic Thymic Epithelial Tumors--A Real-World Assessment of Efficacy and Toxicity.
Journal: Clinical lung cancer
Published: December 22, 2025
Immunotherapy and Radiation for Clinical Perineural Invasion in Cutaneous Squamous Cell Carcinoma.
Journal: Cancers
Published: October 20, 2025
Age and Sex Correlations with Melanoma Outcomes (Nodal Status, Survival Melanoma in Pregnancy, and Spitzoid Lesions).
Journal: Surgical oncology clinics of North America
Published: May 24, 2025
NeoACTIVATE Arm C: Phase II trial of neoadjuvant atezolizumab and tiragolumab for high-risk operable Stage III melanoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 10, 2025
Tumour-infiltrating lymphocyte therapy landscape: prospects and challenges.
Journal: BMJ oncology
Published: April 08, 2025
Expanding the spectrum of fusion partners for cystic TFE3-rearranged renal cell carcinomas: A report of a MAPK1IP1L::TFE3-rearranged renal cell carcinoma.
Journal: Human pathology
Published: August 30, 2024
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital setting.
Journal: Melanoma research
Published: August 29, 2024
Transforming the oncology data paradigm by creating, capturing, and retrieving structured cancer data at the point of care: A Mayo Clinic pilot.
Journal: Cancer
Published: November 13, 2023
Clinical outcomes of atezolizumab versus standard-of-care docetaxel with and without ramucirumab in patients with advanced non-small-cell lung cancer who received prior immunotherapy.
Journal: Frontiers in oncology
Published: October 03, 2023
Brief report: risk stratification following curative therapy for stage I NSCLC.
Journal: Frontiers in oncology
Published: June 29, 2023
Arsenic trioxide suppresses lung adenocarcinoma stem cell stemness by inhibiting m6A modification to promote ferroptosis.
Journal: American journal of cancer research
Published: March 06, 2023
Last Updated: 09/26/2026